The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach.

Huang, Ting-Ting; Wang, Xin; Qiang, Shao-Jia; Zhao, Zhen-Nan; Wu, Zhuo-Xun; Ashby, Charles R; Li, Jia-Zhong; Chen, Zhe-Sheng

Huang, Ting-Ting; Wang, Xin; Qiang, Shao-Jia; Zhao, Zhen-Nan; Wu, Zhuo-Xun; Ashby, Charles R; Li, Jia-Zhong; Chen, Zhe-Sheng.

Affiliation

Huang TT; School of Pharmacy, Lanzhou University, Lanzhou, China.
Wang X; School of Pharmacy, Lanzhou University, Lanzhou, China.
Qiang SJ; School of Pharmacy, Lanzhou University, Lanzhou, China.
Zhao ZN; School of Pharmacy, Lanzhou University, Lanzhou, China.
Wu ZX; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Ashby CR; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Li JZ; School of Pharmacy, Lanzhou University, Lanzhou, China.
Chen ZS; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.

Front Cell Dev Biol ; 9: 649434, 2021.

Article de En | MEDLINE | ID: mdl-33748144

Mots clés

BCR-ABL; CML; ZINC21710815; apoptosis; autophagy; pharmacophore model

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Screening_studies Langue: En Journal: Front Cell Dev Biol Année: 2021 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google